Page last updated: 2024-08-21

3-hydroxyflavone and Leishmaniasis

3-hydroxyflavone has been researched along with Leishmaniasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alunda, JM; Baptista, C; Bifeld, E; Borsari, C; Clos, J; Cordeiro-da-Silva, A; Corral, MJ; Costantino, L; Costi, MP; Eick, J; Ellinger, B; Ferrari, S; Franco, CH; Gul, S; Jiménez-Antón, MD; Kuzikov, M; Linciano, P; Luciani, R; Moraes, CB; Olías-Molero, AI; Ponterini, G; Reinshagen, J; Santarem, N; Severi, L; Tait, A; Tejera Nevado, P; Torrado, JJ; Witt, G; Wolf, M; Zander-Dinse, D1
da Silva, ER; dos Reis, MB; Manjolin, LC; Maquiaveli, Cdo C; Santos-Filho, OA1

Other Studies

2 other study(ies) available for 3-hydroxyflavone and Leishmaniasis

ArticleYear
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Animals; Antiprotozoal Agents; Cricetinae; Drug Evaluation, Preclinical; Drug Resistance; Flavonols; Genomics; Humans; Leishmania; Leishmaniasis; Phosphorylcholine; Thiophenes

2019
Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection.
    Food chemistry, 2013, Dec-01, Volume: 141, Issue:3

    Topics: Arginase; Catalytic Domain; Enzyme Inhibitors; Flavonoids; Flavonols; Humans; Kinetics; Leishmania; Leishmaniasis; Luteolin; Models, Molecular; Molecular Structure; Protozoan Proteins

2013